Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II IL-12 and IL-2 in Mycosis Fungoides
NCT00052377Phase 2Terminated
- Sponsor
- National Cancer Institute
- Start
- Sep 2002
- Primary completion
- Jun 2005
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of aldesleukin, recombinant interleukin-12 in mycosis fungoides (MF), sponsored by National Cancer Institute. Started Sep 2002; status: terminated.
02
Drugs
aldesleukinrecombinant interleukin-12
03
Conditions
mycosis fungoides (MF)
Beyond the preview
Go deeper on NCT00052377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00052377.